Rep. Doggett: FDA Should Test Whether Drugs Are Better Than Existing Treatments

Rep. Lloyd Doggett (D-TX) said FDA could be doing more to ensure that drugs coming to market have clear evidence of effectiveness by testing whether products going through the pipeline are better than existing therapies, echoing calls by policy and stakeholder groups, as well as Democratic presidential candidate Hillary Clinton, for more comparative effectiveness research. But Doggett told Inside Health Policy he also believes a drug's approval should not hinge on whether it is superior to other treatments, stressing...